Project documents | Emapalumab for treating primary haemophagocytic lymphohistiocytosis (ID1438) | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 183 KB)

Published:

30 August 2019
Equality impact assessment (Scoping) (PDF 125 KB)

Published:

30 August 2019
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 289 KB)

Published:

30 August 2019
Final stakeholder list (PDF 191 KB)

Published:

30 August 2019

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope pre referral (PDF 342 KB)

Published:

31 July 2018
Draft matrix pre referral (PDF 254 KB)

Published:

31 July 2018